Treatment.com International (TSE:TRUE) has released an update.
Treatment.com AI has struck a deal to pay an independent consultant in shares for advisory services. The agreement, effective from July 29 to September 10, 2024, will award the consultant with nearly 40,000 shares, valued at $0.77 each, after a four-month holding period. This move showcases the AI healthcare company’s commitment to leveraging its Global Library of Medicine platform to enhance healthcare delivery and education.
For further insights into TSE:TRUE stock, check out TipRanks’ Stock Analysis page.
